View in EDS

Representativeness and adverse event reporting in late-phase clinical trials for rifampin-susceptible tuberculosis: a systematic review.

Saved in:
Bibliographic Details
Title: Representativeness and adverse event reporting in late-phase clinical trials for rifampin-susceptible tuberculosis: a systematic review.
Authors: Burman W; Public Health Institute, Denver Health, Denver, CO, USA; Department of Medicine, University of Colorado Anschutz Medical Campus, Denver, CO, USA. Electronic address: bill.burman@dhha.org., Luczynski P; Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada., Horsburgh CR; Department of Global Health, Department of Epidemiology, and Department of Biostatistics, School of Public Health, Boston University, Boston, MA, USA; Department of Medicine, School of Medicine, Boston University, Boston, MA, USA., Phillips PPJ; Department of Medicine, University of California San Francisco, San Francisco, CA, USA., Johnston J; Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada; Provincial TB Services, British Columbia Centre for Disease Control, Vancouver, BC, Canada.
Source: The Lancet. Infectious diseases [Lancet Infect Dis] 2025 Feb; Vol. 25 (2), pp. e86-e98. Date of Electronic Publication: 2024 Nov 26.
Publication Type: Journal Article; Systematic Review; Meta-Analysis
Journal Info: Publisher: Elsevier Science Country of Publication: United States NLM ID: 101130150 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-4457 (Electronic) Linking ISSN: 14733099 NLM ISO Abbreviation: Lancet Infect Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39612926
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Representativeness and adverse event reporting in late-phase clinical trials for rifampin-susceptible tuberculosis: a systematic review.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Burman+W%22">Burman W</searchLink>; Public Health Institute, Denver Health, Denver, CO, USA; Department of Medicine, University of Colorado Anschutz Medical Campus, Denver, CO, USA. Electronic address: bill.burman@dhha.org.<br /><searchLink fieldCode="AU" term="%22Luczynski+P%22">Luczynski P</searchLink>; Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Horsburgh+CR%22">Horsburgh CR</searchLink>; Department of Global Health, Department of Epidemiology, and Department of Biostatistics, School of Public Health, Boston University, Boston, MA, USA; Department of Medicine, School of Medicine, Boston University, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Phillips+PPJ%22">Phillips PPJ</searchLink>; Department of Medicine, University of California San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Johnston+J%22">Johnston J</searchLink>; Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada; Provincial TB Services, British Columbia Centre for Disease Control, Vancouver, BC, Canada.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101130150%22">The Lancet. Infectious diseases</searchLink> [Lancet Infect Dis] 2025 Feb; Vol. 25 (2), pp. e86-e98. <i>Date of Electronic Publication: </i>2024 Nov 26.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Systematic Review; Meta-Analysis
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science%22">Elsevier Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101130150 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1474-4457 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214733099%22">14733099 </searchLink><i>NLM ISO Abbreviation: </i>Lancet Infect Dis <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39612926
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/S1473-3099(24)00597-8
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e86
    Titles:
      – TitleFull: Representativeness and adverse event reporting in late-phase clinical trials for rifampin-susceptible tuberculosis: a systematic review.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Burman W
      – PersonEntity:
          Name:
            NameFull: Luczynski P
      – PersonEntity:
          Name:
            NameFull: Horsburgh CR
      – PersonEntity:
          Name:
            NameFull: Phillips PPJ
      – PersonEntity:
          Name:
            NameFull: Johnston J
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 02
              Text: 2025 Feb
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1474-4457
          Numbering:
            – Type: volume
              Value: 25
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: The Lancet. Infectious diseases
              Type: main
ResultId 1